Ubivac

Developer of dendritic cell (DC)-targeted complex vaccine combination immunotherapy for cancer

placePortland, Oregon, United States calendar_todayFounded 2005 groups5 employees language ubivac.com

Registered entities

Innovation

2 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 122 times.

YearFilings
20141
20152
20162
20171
20181
20192
20201

Social engagement

Social engagement: 926 social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%

Recent activity

24 Sep 2025
Event
SITC 2025
Coming soon